LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 86.79 | 17.25 | 6904 | 6008 | 1.1491 | 1.0332 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 88.76 | 17.25 | 45 | 6047 | 0.0074 | 0.1201 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 88.76 | 17.25 | 6864 | 6047 | 1.1349 | 1.0302 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 88.76 | 17.25 | 18 | 6047 | 0.0030 | 0.0050 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 88.76 | 17.25 | 7002 | 6047 | 1.1578 | 1.0350 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 90.74 | 17.25 | 43 | 6109 | 0.0070 | 0.1139 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 90.74 | 17.25 | 6889 | 6109 | 1.1276 | 1.0286 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 90.74 | 17.25 | 10 | 6109 | 0.0016 | -0.0624 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 90.74 | 17.25 | 7110 | 6109 | 1.1637 | 1.0361 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 92.71 | 17.25 | 30 | 6184 | 0.0049 | 0.0674 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 92.71 | 17.25 | 6979 | 6184 | 1.1285 | 1.0287 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 92.71 | 17.25 | 2 | 6184 | 0.0003 | -0.2243 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 92.71 | 17.25 | 7192 | 6184 | 1.1630 | 1.0359 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 94.68 | 17.25 | 8 | 6239 | 0.0013 | -0.0865 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 94.68 | 17.25 | 7031 | 6239 | 1.1269 | 1.0283 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 94.68 | 17.25 | 1 | 6239 | 0.0002 | -0.2847 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 94.68 | 17.25 | 7190 | 6239 | 1.1524 | 1.0337 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | C22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 3.06 | 17.25 | 347 | 143 | 2.4229 | 1.6724 | MN20160310_N02 | C22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | F04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 3.06 | 17.25 | 293 | 143 | 2.0459 | 1.5284 | MN20160310_N02 | F04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 5.03 | 17.25 | 3 | 273 | 0.0110 | -0.3552 | MN20160310_N02 | C22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 5.03 | 17.25 | 565 | 273 | 2.0669 | 1.3996 | MN20160310_N02 | C22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | F04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 5.03 | 17.25 | 699 | 273 | 2.5571 | 1.5312 | MN20160310_N02 | F04 |